Extracellular Nucleophosmin Is Increased in Psoriasis and Correlates With the Determinants of Cardiovascular Diseases
Authors:
Open Access
- 28 April 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 867813
Abstract
We previously showed that genotoxic stress induced an active extracellular release of nucleophosmin (NPM) in human cardiac mesenchymal progenitor cells, and that serum deprivation provokes NPM secretion from human endothelial cells, eliciting inflammation via nuclear factor kappa B (NF-kB) transcriptional activation. In this study, we wanted to determine whether NPM was similarly modulated in the skin and plasma of psoriatic patients (Pso). We found that NPM was induced in 6 skin biopsies compared to 6 normal skin biopsies and was markedly increased in lesional (LS) vs. non-lesional skin (NLS) biopsies. Moreover, NPM was also increased at the transcriptional levels in LS vs. NLS. Both the innate stimuli, such as lipopolysaccharides and Poly inositol–cytosine and adaptive stimuli, that is, cytokine mix, were able to induce the extracellular release of NPM in immortalized keratinocytes and human skin fibroblasts in the absence of cytotoxicity. Interestingly, NPM interacts with Toll-like receptor (TLR)4 in these cells and activates an NF-kB-dependent inflammatory pathway upregulating interleukin IL-6 and COX-2 gene expression. Finally, circulating NPM was increased in the plasma of 29 Pso compared to 29 healthy controls, and positively correlates with psoriasis area severity index (PASI) and with determinants of cardiovascular diseases (CVDs), such as pulse wave velocity, systolic pressure, and left ventricular mass. Furthermore, NPM positively correlates with miR-200c circulating levels, which we previously showed to increase in Pso and correlate with CVD progression. Our data show that circulating miR-200c is physically associated with extracellular NPM, which most probably is responsible for its extracellular release and protection upon cytokine mix via a TLR4-mechanism. In conclusion, NPM is increased in psoriasis both in the skin and plasma and might be considered a novel biologic target to counteract chronic inflammation associated with CVD risk.Keywords
Funding Information
- Ministero della Salute
- French Muscular Dystrophy Association
- Regione Lazio
This publication has 41 references indexed in Scilit:
- Discovery and Validation of a New Class of Small Molecule Toll-Like Receptor 4 (TLR4) InhibitorsPLOS ONE, 2013
- Expression and Functional Studies on the Noncoding RNA, PRINSInternational Journal of Molecular Sciences, 2012
- miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibitionCell Death & Differentiation, 2011
- Export of microRNAs and microRNA-protective protein by mammalian cellsNucleic Acids Research, 2010
- Nucleophosmin Blocks Mitochondrial Localization of p53 and ApoptosisJournal of Biological Chemistry, 2009
- Divergent Effects of Laughter and Mental Stress on Arterial Stiffness and Central HemodynamicsPsychosomatic Medicine, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Direct observation of individual endogenous protein complexes in situ by proximity ligationNature Methods, 2006
- Acute Mental Stress Has a Prolonged Unfavorable Effect on Arterial Stiffness and Wave ReflectionsPsychosomatic Medicine, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001